Kisspeptin: A Single Peptide That Links Fertility and Metabolism, with Therapeutic Potential for Both
Kisspeptins regulate both reproduction and metabolism in a sex-dependent manner, and disruptions in kisspeptin signaling are implicated in diabetes, obesity, PCOS, and hypogonadism — making them a dual therapeutic target.
Quick Facts
What This Study Found
Kisspeptins regulate both reproduction and metabolism in a sexually dimorphic manner, with disruptions in metabolic conditions leading to simultaneous reproductive dysfunction. Only 15% of clinical studies address kisspeptin's metabolic role.
Key Numbers
Kisspeptin acts through receptors in the brain, brown adipose tissue, and pancreas.
How They Did This
Narrative review of experimental (animal model) and clinical evidence on kisspeptin's dual role in metabolism and reproduction, covering diabetes, obesity, undernutrition, PCOS, and hypogonadism.
Why This Research Matters
Many metabolic disorders coexist with reproductive problems (e.g., PCOS with insulin resistance, obesity with hypogonadism). A peptide that links both systems could enable treatments addressing root causes rather than treating metabolic and reproductive issues separately.
The Bigger Picture
The discovery that kisspeptin connects two fundamental biological systems — reproduction and metabolism — opens a new frontier in peptide therapeutics. This is particularly relevant for conditions like PCOS, where metabolic and reproductive dysfunction are deeply intertwined.
What This Study Doesn't Tell Us
Narrative review with limited systematic methodology. Clinical evidence for metabolic effects of kisspeptin is still sparse. The sexual dimorphism in kisspeptin's metabolic actions complicates therapeutic development. Most metabolic data comes from animal models.
Questions This Raises
- ?Could kisspeptin-based therapies simultaneously improve metabolic and reproductive outcomes in PCOS patients?
- ?What explains the sex-dependent differences in kisspeptin's metabolic effects?
- ?Would kisspeptin receptor agonists be more effective than GLP-1 drugs for metabolically-driven infertility?
Trust & Context
- Key Stat:
- Only 15% of studies address metabolism Despite clear evidence of kisspeptin's metabolic role, the vast majority of clinical research has focused exclusively on fertility
- Evidence Grade:
- Preliminary to moderate evidence. Strong preclinical support across multiple animal models, but limited clinical evidence for metabolic applications.
- Study Age:
- Published in 2024. Highlights an emerging and rapidly expanding field of kisspeptin research.
- Original Title:
- Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction.
- Published In:
- Journal of diabetes, 16(4), e13541 (2024)
- Authors:
- Sliwowska, Joanna Helena, Woods, Nicola Elizabeth, Alzahrani, Abdullah Rzgallah, Paspali, Elpiniki, Tate, Rothwelle Joseph, Ferro, Valerie Anne
- Database ID:
- RPEP-09287
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What is kisspeptin?
Kisspeptin is a peptide hormone that acts as a master switch for reproduction by triggering the release of gonadotropin-releasing hormone. It was originally discovered as a tumor suppressor. Now it's recognized as also playing important roles in metabolism, including glucose regulation and fat metabolism.
How could kisspeptin help with conditions like PCOS?
PCOS involves both reproductive dysfunction (irregular ovulation) and metabolic problems (insulin resistance). Since kisspeptin regulates both systems, targeting kisspeptin signaling could potentially address the root connection between these problems rather than treating each separately.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09287APA
Sliwowska, Joanna Helena; Woods, Nicola Elizabeth; Alzahrani, Abdullah Rzgallah; Paspali, Elpiniki; Tate, Rothwelle Joseph; Ferro, Valerie Anne. (2024). Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction.. Journal of diabetes, 16(4), e13541. https://doi.org/10.1111/1753-0407.13541
MLA
Sliwowska, Joanna Helena, et al. "Kisspeptin a potential therapeutic target in treatment of both metabolic and reproductive dysfunction.." Journal of diabetes, 2024. https://doi.org/10.1111/1753-0407.13541
RethinkPeptides
RethinkPeptides Research Database. "Kisspeptin a potential therapeutic target in treatment of bo..." RPEP-09287. Retrieved from https://rethinkpeptides.com/research/sliwowska-2024-kisspeptin-a-potential-therapeutic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.